secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2026-05-26T12:00:15+00:00
Accession:  0001193125-26-237908
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology President & COO Bellete to depart June 30; CEO Kuan becomes President
--------------------------------------------------------------------------------

- Ambaw Bellete, President & COO, agreed to separation effective June 30, 2026; severance per existing employment agreement.
- Arthur Kuan appointed as President in addition to his other roles, effective upon Bellete's departure.
- Company has initiated a search for a Chief Commercial Officer.
- No reason for departure given; transition appears orderly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526237908/0001193125-26-237908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526237908/ck0001991792-20260520.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-237908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer